AAV2-GAD gene therapy for advanced Parkinson's disease: A double-blind, sham-surgery controlled, randomised trial.
The Lancet Neurology.
Times cited: 304
Urate as a predictor of the rate of clinical decline in Parkinson disease.
Archives of Neurology.
Times cited: 171
Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results.
Times cited: 1092